228 related articles for article (PubMed ID: 19821298)
21. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
Tzellos TG; Kouvelas D
Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
[TBL] [Abstract][Full Text] [Related]
22. Management of cutaneous manifestations of lupus erythematosus: A systematic review.
Fairley JL; Oon S; Saracino AM; Nikpour M
Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594
[TBL] [Abstract][Full Text] [Related]
23. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
24. Acitretin treatment in antimalarial-refractory/intolerant discoid lupus erythematosus: A prospective, open-label, uncontrolled study.
Laosakul K; Chiewchanvit S; Chuamanochan M; Tovanabutra N
Lupus; 2022 Apr; 31(5):575-581. PubMed ID: 35306922
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
26. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.
Barikbin B; Givrad S; Yousefi M; Eskandari F
Clin Exp Dermatol; 2009 Oct; 34(7):776-80. PubMed ID: 19456797
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of a novel generalized variant of canine discoid lupus erythematosus with oral hydroxychloroquine.
Oberkirchner U; Linder KE; Olivry T
Vet Dermatol; 2012 Feb; 23(1):65-70, e15-6. PubMed ID: 21718370
[TBL] [Abstract][Full Text] [Related]
28. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effectiveness of topical tacrolimus 0.1% vs topical halobetasol propionate 0.05% as an add-on to oral hydroxychloroquine in discoid lupus erythematosus.
Barua DP; Chowdhury MIH; Mowla MR; Reich A; Murrell D; Ruzicka T
Dermatol Ther; 2021 Jan; 34(1):e14675. PubMed ID: 33320408
[TBL] [Abstract][Full Text] [Related]
30. Interventions for rosacea.
van Zuuren EJ; Kramer S; Carter B; Graber MA; Fedorowicz Z
Cochrane Database Syst Rev; 2011 Mar; (3):CD003262. PubMed ID: 21412882
[TBL] [Abstract][Full Text] [Related]
31. Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab.
Ocon A; Avalos Sugastti E; Duffy N
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38890107
[TBL] [Abstract][Full Text] [Related]
32. Advances in the treatment of cutaneous lupus erythematosus.
Kuhn A; Landmann A; Wenzel J
Lupus; 2016 Jul; 25(8):830-7. PubMed ID: 27252259
[TBL] [Abstract][Full Text] [Related]
33. Unsuccessful treatment of recalcitrant cutaneous discoid lupus erythematosus with photodynamic therapy.
Romero-Maté A; Castaño-Suárez E; García-Donoso C; Martínez-Morán C; Meseguer-Yebra C; Borbujo J
Photodermatol Photoimmunol Photomed; 2010 Jun; 26(3):156-8. PubMed ID: 20584256
[TBL] [Abstract][Full Text] [Related]
34. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
Cochrane Database Syst Rev; 2006 Apr; (2):CD002265. PubMed ID: 16625558
[TBL] [Abstract][Full Text] [Related]
35. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.
Sontheimer RD; Thomas JR; Gilliam JN
Arch Dermatol; 1979 Dec; 115(12):1409-15. PubMed ID: 533284
[TBL] [Abstract][Full Text] [Related]
36. Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a.
Nicolas JF; Thivolet J; Kanitakis J; Lyonnet S
J Invest Dermatol; 1990 Dec; 95(6 Suppl):142S-145S. PubMed ID: 2258631
[TBL] [Abstract][Full Text] [Related]
37. Dramatic effect of hydroxychloroquine on lupus alopecia.
Igari S; Yamamoto T
J Dermatol; 2018 Feb; 45(2):194-197. PubMed ID: 29068087
[TBL] [Abstract][Full Text] [Related]
38. Treatment for ulnar neuropathy at the elbow.
Caliandro P; La Torre G; Padua R; Giannini F; Padua L
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006839. PubMed ID: 27845501
[TBL] [Abstract][Full Text] [Related]
39. A secondary discoid lupus erythematosus induced by scald of edible oil: An illustration of Koebner phenomenon.
Ji YZ; Mei XL; Wei FL; Liu SR; Ji YB
J Cosmet Dermatol; 2020 Jul; 19(7):1699-1701. PubMed ID: 31660688
[TBL] [Abstract][Full Text] [Related]
40. Topical niacinamide (Nicotinamide) treatment for discoid lupus erythematosus (DLE): A prospective pilot study.
Nouh AH; Elshahid AR; Kadah AS; Zeyada YA
J Cosmet Dermatol; 2023 May; 22(5):1647-1657. PubMed ID: 36683259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
